ExploreWatchlistsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Revenue growth (%)

KISSEI PHARMACEUTICAL CO.,LTD. (4547)

Market cap
¥230.7B
P/E ratio
15.8x
Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 202516.9+40.82%
Mar 31, 202412+270.90%
Mar 31, 20233.2-160.83%
Mar 31, 2022-5.3-157.78%
Mar 31, 20219.2-173.29%
Mar 31, 2020-12.5+442.86%
Mar 31, 2019-2.3-171.96%
Mar 31, 20183.2+453.45%
Mar 31, 20170.6-65.68%
Mar 31, 20161.7-512.20%
Mar 31, 2015-0.4-103.24%
Mar 31, 201412.7-484.50%
Mar 31, 2013-3.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat